Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Galectin-1 as an oncotarget in gliomas and melanomas.
Lefranc F, Mathieu V, Kiss R. Lefranc F, et al. Among authors: mathieu v. Oncotarget. 2011 Dec;2(12):892-3. doi: 10.18632/oncotarget.408. Oncotarget. 2011. PMID: 22248884 Free PMC article. No abstract available.
Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. Le Mercier M, et al. Among authors: mathieu v. Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83. doi: 10.1016/j.taap.2008.01.009. Epub 2008 Jan 29. Toxicol Appl Pharmacol. 2008. PMID: 18313712
Galectins and gliomas.
Le Mercier M, Fortin S, Mathieu V, Kiss R, Lefranc F. Le Mercier M, et al. Among authors: mathieu v. Brain Pathol. 2010 Jan;20(1):17-27. doi: 10.1111/j.1750-3639.2009.00270.x. Epub 2009 Apr 7. Brain Pathol. 2010. PMID: 19371355 Free PMC article. Review.
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T, Toelen J, Maes W, Poirier F, Boon L, Tousseyn T, Mathivet T, Gerhardt H, Mathieu V, Kiss R, Lefranc F, Van Gool SW, De Vleeschouwer S. Verschuere T, et al. Among authors: mathieu v. Int J Cancer. 2014 Feb 15;134(4):873-84. doi: 10.1002/ijc.28426. Epub 2013 Sep 4. Int J Cancer. 2014. PMID: 23929302 Free article.
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Van Woensel M, Wauthoz N, Rosière R, Mathieu V, Kiss R, Lefranc F, Steelant B, Dilissen E, Van Gool SW, Mathivet T, Gerhardt H, Amighi K, De Vleeschouwer S. Van Woensel M, et al. Among authors: mathieu v. J Control Release. 2016 Apr 10;227:71-81. doi: 10.1016/j.jconrel.2016.02.032. Epub 2016 Feb 21. J Control Release. 2016. PMID: 26902800
Galectin-1 in melanoma biology and related neo-angiogenesis processes.
Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcène A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, Van Gool S, Poirier F, Castronovo V, Kiss R, Feron O. Mathieu V, et al. J Invest Dermatol. 2012 Sep;132(9):2245-54. doi: 10.1038/jid.2012.142. Epub 2012 May 24. J Invest Dermatol. 2012. PMID: 22622427 Free article.
Anti-galectin compounds as potential anti-cancer drugs.
Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Ingrassia L, et al. Among authors: mathieu v. Curr Med Chem. 2006;13(29):3513-27. doi: 10.2174/092986706779026219. Curr Med Chem. 2006. PMID: 17168720 Review.
158 results